The 2026 Satinder Ahuja Award for Young Investigators in Separation Science will be presented to Justin Godinho of GSK, who will speak on Increasing Separation Efficiency and Speed, focusing on ...
The conference convened Organic & Natural Health members, board leaders, and industry stakeholders from across the supply ...
Would you like your students to learn about the weather from trusted local meteorologists? If the answer is yes, you've come to the right place. Storm Team4 has developed a short science lesson that ...
Forbes contributors publish independent expert analyses and insights. I write about relationships, personality, and everyday psychology. We’ve all experienced that moment of “cinematic” recognition. A ...
NEW YORK (AP) — NASA is cutting a mission aboard the International Space Station short after an astronaut had a medical issue. The space agency said Thursday the U.S.-Japanese-Russian crew of four ...
Forbes contributors publish independent expert analyses and insights. I write about relationships, personality, and everyday psychology. Why do some people fall hard and fast, while others move more ...
How you walk may matter just as much as how much you walk. A large UK study tracking more than 33,000 low-activity adults found that people who grouped their daily steps into longer, uninterrupted ...
It's quick and easy to access Live Science Plus, simply enter your email below. We'll send you a confirmation and sign you up for our daily newsletter, keeping you up to date with the latest science ...
Tracey Marks, M.D., is a psychiatrist, mental health educator, and author who helps people strengthen their minds using practical,… In this video from our Bridging Differences for Parents and Teens ...
Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. For Hawaii’s short-finned pilot whales (Globicephala ...
CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (Lerochol®), a novel, monthly, small dose third-generation PCSK9 ...
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results